FDA conditionally approved

As we announced this morning below, crofelemer, our prescription drug conditionally approved by the FDA for chemotherapy-induced diarrhea in dogs, is the subject of the Investigational New Animal Drug application we've filed with the FDA for the indication of general diarrhea in dogs. We estimate that U.S. veterinarians see approximately six million annual cases of acute and chronic diarrhea in dogs, and we look forward to evaluating the possibility of expanding the indication of crofelemer to include treatment of all types of non-infectious diarrhea in dogs.

All the best,
Lisa